Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2007

01-02-2007 | Original Paper

The Use of the Internet in Data Assimilation in Rare Diseases

Authors: Raymond Bedgood, Rafal Sadurski, Robert R. Schade

Published in: Digestive Diseases and Sciences | Issue 2/2007

Login to get access

Abstract

The incidence and prevalence of achalasia is 0.6/100,000 people per year and 1/10,000, respectively. It is difficult then for one center to accumulate a large cohort of patients. One study (Gut 33:1011,1992) described the presenting symptoms in only 38 patients. To approach this problem differently, we used the internet to access a larger patient population. Using search engines at Google™ and Yahoo™, Inc., we identified achalasia support groups. We examined the most populated support group (YSG) and assembled the exchanged messages into 4 categories: support, symptoms, treatment, and diagnosis. Next, a survey modeled after a previous study (ibid) was composed and posted on a university-sponsored Web site for March 2003, advertised to YSG members, and then removed from the server. The results were entered into a database and analyzed. There were 6 support groups identified; 1 was foreign. The most populated site was the Yahoo™, Inc., group with 298 active members. We analyzed the 3,222 messages posted from October 6, 2002 through October 5, 2003. The message composition was as follows: 67% support, 16% symptoms, 12% treatment, and 5% diagnosis. Of 298 Yahoo™ site members, we had 88 respondents to the survey from 9 countries. The data from 83 were analyzed (5 were not completed). Respondents were 66 women (55%), 29 men (24%), and 5 non–gender-identified respondents. They ranged in age from 6 to 72 years at time of diagnosis. In the 83 respondents, dysphagia symptoms were reported by 98%, regurgitation by 68%, chest pain by 81%, weight loss by 69%, and epigastric pain by 67%, similar to those reported in the study cited in Gut. The modalities used to evaluate these achalasia patients were as follows: 83% had monometry, 87% had radiography, and 89% had endoscopy. The mean time from symptom onset to diagnosis was 5 years. The treatments attempted on this population were balloon dilatation in 57%, botulinum toxin injection (Botox) in 8%, myotomy in 12%, by lifestyle/diet modification in 12%, and other treatments in 11%. We believe that the Internet can provide physician–researchers with useful information about common and uncommon diseases on a global basis. The Internet allows patients to voice concerns that they may not freely express to their doctor and provides a modality to collect data from a larger number of patients than may be available at any single institution.
Literature
1.
go back to reference Mayberry JF, Atkinson M (1987) Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions. Q J Med 62:67–71PubMed Mayberry JF, Atkinson M (1987) Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions. Q J Med 62:67–71PubMed
2.
go back to reference Earlam RJ, Ellis FH Jr, Nobrega FT (1969) Achalasia of the esophagus in a small urban community. Mayo Clin Proc 44:478–483PubMed Earlam RJ, Ellis FH Jr, Nobrega FT (1969) Achalasia of the esophagus in a small urban community. Mayo Clin Proc 44:478–483PubMed
3.
go back to reference Howard PJ, Amher L, Pryde A, et al. (1992) Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 33:1011–1015PubMed Howard PJ, Amher L, Pryde A, et al. (1992) Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 33:1011–1015PubMed
4.
go back to reference Meshkinpour H, Kaye L, Elias A, et al. (1992) Manometric and radiologic correlations in achalasia. Am J Gastroenterol 87:1567–1570PubMed Meshkinpour H, Kaye L, Elias A, et al. (1992) Manometric and radiologic correlations in achalasia. Am J Gastroenterol 87:1567–1570PubMed
5.
go back to reference Eckardt VF, Kohne U, Westermeier T (1997) Risk factors for diagnostic delay in achalasia. Dig Dis Sci 42:580–585PubMedCrossRef Eckardt VF, Kohne U, Westermeier T (1997) Risk factors for diagnostic delay in achalasia. Dig Dis Sci 42:580–585PubMedCrossRef
6.
go back to reference Hesse BW, Nelson DE, Kreps GL, et al. (2005) Trust and sources of health information. Arch Intern Med 165:2618–2624PubMedCrossRef Hesse BW, Nelson DE, Kreps GL, et al. (2005) Trust and sources of health information. Arch Intern Med 165:2618–2624PubMedCrossRef
7.
go back to reference Harrington J, Noble LM, Newman SP (2004) Improving patients’ communication with doctors: a systematic review of interventional studies. Patient Educ Couns 52:7–16PubMedCrossRef Harrington J, Noble LM, Newman SP (2004) Improving patients’ communication with doctors: a systematic review of interventional studies. Patient Educ Couns 52:7–16PubMedCrossRef
8.
go back to reference Eysenbach G, Powell J, Englesakis M, Rizo C, et al. (2004) Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. BMJ 328:1166–1170PubMedCrossRef Eysenbach G, Powell J, Englesakis M, Rizo C, et al. (2004) Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. BMJ 328:1166–1170PubMedCrossRef
10.
go back to reference Lorig K, Laurent D, Deyo R, et al. (2002) Can a back pain e-mail discussion group improve health status and lower healthcare costs? Arch Intern Med 162:792–796PubMedCrossRef Lorig K, Laurent D, Deyo R, et al. (2002) Can a back pain e-mail discussion group improve health status and lower healthcare costs? Arch Intern Med 162:792–796PubMedCrossRef
11.
go back to reference Moore JE (2002) Evidence-based health promotion. Evidence-based Healthcare: A Scientific Approach to Health Policy 6:184–185 Moore JE (2002) Evidence-based health promotion. Evidence-based Healthcare: A Scientific Approach to Health Policy 6:184–185
12.
go back to reference Rosenzweig S, Traube M (1989) The diagnosis and misdiagnosis of achalasia. J Clin Gastroenterol 11:147–153PubMedCrossRef Rosenzweig S, Traube M (1989) The diagnosis and misdiagnosis of achalasia. J Clin Gastroenterol 11:147–153PubMedCrossRef
13.
go back to reference Wong RK, Johnson LF (1983) Achalasia. In: Castell DO, Johnson LF (eds) Esophageal Function in Health and Disease. New York, Elsevier Biomedical, 1983, pp 99–123 Wong RK, Johnson LF (1983) Achalasia. In: Castell DO, Johnson LF (eds) Esophageal Function in Health and Disease. New York, Elsevier Biomedical, 1983, pp 99–123
14.
go back to reference Olsen AM, Holman CB, Andersen HA (1953) The diagnosis of cardiospasm. Dis Chest 23:477–498PubMed Olsen AM, Holman CB, Andersen HA (1953) The diagnosis of cardiospasm. Dis Chest 23:477–498PubMed
15.
go back to reference Adams CW, Brain RH, Ellis FG, et al. (1961) Achalasia of the cardia. Guy’s Hosp Rev 110:191–236 Adams CW, Brain RH, Ellis FG, et al. (1961) Achalasia of the cardia. Guy’s Hosp Rev 110:191–236
16.
go back to reference Kim CH, Cameron AJ, Hsu JJ, et al. (1993) Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilatation. Mayo Clin Proc 68:1067–1073PubMed Kim CH, Cameron AJ, Hsu JJ, et al. (1993) Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilatation. Mayo Clin Proc 68:1067–1073PubMed
17.
go back to reference Vaezi MF, Richter JE, Wilcox CM, et al. (1999) Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 44:231–239PubMedCrossRef Vaezi MF, Richter JE, Wilcox CM, et al. (1999) Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 44:231–239PubMedCrossRef
18.
go back to reference Vaezi MF, Richter JE (1998) Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 27:21–35PubMedCrossRef Vaezi MF, Richter JE (1998) Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 27:21–35PubMedCrossRef
19.
go back to reference Hooshang M, Haghighat P, Meshkinpour A (1996) Quality of life among patients treated for achalasia. Dig Dis Sci 41:352–356CrossRef Hooshang M, Haghighat P, Meshkinpour A (1996) Quality of life among patients treated for achalasia. Dig Dis Sci 41:352–356CrossRef
20.
go back to reference Zaninotto G, Annese V, Costantini M, et al. (2004) Randomized controlled trial of botulinum toxin versus laparaoscopic Heller myotomy for esophageal achalasia. Ann Surg 239:364– 370PubMedCrossRef Zaninotto G, Annese V, Costantini M, et al. (2004) Randomized controlled trial of botulinum toxin versus laparaoscopic Heller myotomy for esophageal achalasia. Ann Surg 239:364– 370PubMedCrossRef
21.
go back to reference Bansal R, Nostrant TT, Scheiman JM, et al. (2003) Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol 36:209–214PubMedCrossRef Bansal R, Nostrant TT, Scheiman JM, et al. (2003) Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol 36:209–214PubMedCrossRef
22.
go back to reference Ghoshal UC, Chaudhuri S, Pal BB, et al. (2001) Randomized controlled trial of intrasphincteric botulinum toxin A versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus 14:227–231PubMedCrossRef Ghoshal UC, Chaudhuri S, Pal BB, et al. (2001) Randomized controlled trial of intrasphincteric botulinum toxin A versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus 14:227–231PubMedCrossRef
23.
go back to reference Karamanolis G, Sgouros S, Karatzias G, et al. (2005) Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 100:270–274PubMedCrossRef Karamanolis G, Sgouros S, Karatzias G, et al. (2005) Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 100:270–274PubMedCrossRef
Metadata
Title
The Use of the Internet in Data Assimilation in Rare Diseases
Authors
Raymond Bedgood
Rafal Sadurski
Robert R. Schade
Publication date
01-02-2007
Published in
Digestive Diseases and Sciences / Issue 2/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9213-2

Other articles of this Issue 2/2007

Digestive Diseases and Sciences 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine